Analyst rating accuracy & track record
Michael King is an equity research analyst at EF Hutton. Bullish Whales has scored 23 of their stock calls across 5 companies. Their picks beat their sector 36% of the time over the next 12 months, and their price targets were reached 29% of the time within a year.
Track record
Bullish Whales has scored 23 of Michael King's stock calls across 5 companies, dating back to 2022. Their rated stocks beat their own sector 36% of the time over the next 12 months. On a typical call, a King pick returned −9.8% more than its sector over the following year.
Of the scored calls, 23 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.
Coverage & ratings
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 APLMApollomics Inc. Class A Ordinary Shares | Buy | $6.50 | Apr 2024 | −90.6% | Miss |
| APLMApollomics Inc. Class A Ordinary Shares | Buy | $25.00 | Aug 2023 | −116.2% | Miss |
 LTRNLantern Pharma Inc | Buy | $11.00 | Aug 2023 | −32.6% | Hit |
| LTRNLantern Pharma Inc | Buy | $11.00 | Jun 2023 | −36.2% | Hit |
 JSPRJasper Therapeutics Inc | Buy | $6.85 | Jun 2023 | +26.4% | Miss |
| LTRNLantern Pharma Inc | Buy | $11.00 | May 2023 | +14.4% | Hit |
 HOWLWerewolf Therapeutics Inc | Buy | $8.30 | May 2023 | +56.7% | Miss |
| APLMApollomics Inc. Class A Ordinary Shares | Buy | $25.00 | May 2023 | −109.1% | Miss |
 BMEABiomea Fusion Inc | Buy | $32.00 | May 2023 | −80.1% | Hit |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | May 2023 | +34.4% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | May 2023 | +23.1% | Miss |
| APLMApollomics Inc. Class A Ordinary Shares | Buy | $25.00 | Apr 2023 | −99.8% | Miss |
| HOWLWerewolf Therapeutics Inc | Buy | $8.30 | Mar 2023 | +140.2% | Miss |
| LTRNLantern Pharma Inc | Buy | $11.00 | Mar 2023 | +85.7% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | Mar 2023 | +39.3% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | Feb 2023 | −8.4% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | Feb 2023 | −8.3% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | Feb 2023 | −5.3% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $6.85 | Feb 2023 | −8.1% | Miss |
| LTRNLantern Pharma Inc | Buy | $11.00 | Feb 2023 | −36.9% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $4.00 | Jan 2023 | −59.4% | Miss |
| LTRNLantern Pharma Inc | Buy | $11.00 | Nov 2022 | −37.1% | Miss |
| JSPRJasper Therapeutics Inc | Buy | $4.00 | Nov 2022 | −3.3% | Miss |
Michael King: analyst track record FAQ
Is Michael King a good stock analyst?
Yes, by track record. Michael King ranks number 211 of 347 of the analysts Bullish Whales scores, with a BW Score of 21 out of 100. Past results do not guarantee future ones.
What is Michael King's win rate?
Michael King's win rate is 36%. Across 23 scored calls, their rated stocks beat their sector 36% of the time over the next 12 months. On a typical call they returned −9.8% more than the sector.
What stocks and sectors does Michael King cover?
Michael King covers 5 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.
Are Michael King's price targets accurate?
Michael King's price targets are reached within 12 months 29% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.
How accurate are Wall Street analyst price targets?
Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.
Should I follow Michael King's stock ratings?
Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.
How does Bullish Whales score analyst accuracy?
Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.
How does Michael King rank among Wall Street analysts?
Michael King ranks number 211 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.